Cytovance Biologics and Selexys form manufacturing collaboration
The Selexys Pharmaceutical project is to be executed in Cytovance’s multi-product process development and cGMP production facility in Oklahoma City over the next 15 months. The 44,000sqft facility
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.